Insulet Corporation (PODD)
NASDAQ: PODD · Real-Time Price · USD
339.88
+2.28 (0.68%)
At close: Aug 29, 2025, 4:00 PM
335.00
-4.88 (-1.44%)
After-hours: Aug 29, 2025, 6:38 PM EDT
Insulet Employees
Insulet had 3,900 employees as of December 31, 2024. The number of employees increased by 900 or 30.00% compared to the previous year.
Employees
3,900
Change (1Y)
900
Growth (1Y)
30.00%
Revenue / Employee
$605,000
Profits / Employee
$60,538
Market Cap
23.93B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3,900 | 900 | 30.00% |
Dec 31, 2023 | 3,000 | 400 | 15.38% |
Dec 31, 2022 | 2,600 | 300 | 13.04% |
Dec 31, 2021 | 2,300 | 400 | 21.05% |
Dec 31, 2020 | 1,900 | 550 | 40.74% |
Dec 31, 2019 | 1,350 | 181 | 15.48% |
Dec 31, 2018 | 1,169 | 312 | 36.41% |
Dec 31, 2017 | 857 | 217 | 33.91% |
Dec 31, 2016 | 640 | -7 | -1.08% |
Dec 31, 2015 | 647 | 128 | 24.66% |
Dec 31, 2014 | 519 | 41 | 8.58% |
Dec 31, 2013 | 478 | -60 | -11.15% |
Dec 31, 2012 | 538 | -38 | -6.60% |
Dec 31, 2011 | 576 | 266 | 85.81% |
Dec 31, 2010 | 310 | 34 | 12.32% |
Dec 31, 2009 | 276 | -18 | -6.12% |
Dec 31, 2008 | 294 | 47 | 19.03% |
Dec 31, 2007 | 247 | -47 | -15.99% |
Dec 31, 2006 | 294 | 47 | 19.03% |
Dec 31, 2005 | 247 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PODD News
- 5 days ago - Insulet Elevates Eric Benjamin to Chief Operating Officer - Business Wire
- 12 days ago - Insulet to Participate in Upcoming Investor Conferences - Business Wire
- 15 days ago - 20 stocks in the S&P 500 that are high achievers this earnings season - Market Watch
- 17 days ago - Insulet's Q2 Beat Is Impressive, But The Elevated Valuation Makes The Stock A Hold - Seeking Alpha
- 23 days ago - Insulet Lifts Annual Forecast On Increased Adoption For Insulin Pump Omnipod 5 - Benzinga
- 23 days ago - Insulet Corporation (PODD) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 23 days ago - Insulet beats second-quarter profit estimates on strong demand for insulin pumps - Reuters
- 23 days ago - Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency1) - Business Wire